US 10258631
Formulations of testosterone and methods of treatment therewith
granted A61KA61K31/568A61K31/5685
Quick answer
US patent 10258631 (Formulations of testosterone and methods of treatment therewith) held by The Board of Regents of the University of Texas System expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/568, A61K31/5685, A61K31/573, A61K45/06